scorecardresearch
Add as a preferred source on Google
Monday, September 29, 2025
TopicSerum Institute India

Topic: Serum Institute India

After public spat, Bharat Biotech & SII jointly pledge smooth roll out of Covid vaccines

The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.

Serum Institute, Bharat Biotech, Cadila vaccines — sifting science from non-science

In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.

Respect govt decision to bar Covishield export, expect nod in March-April, says Serum CEO

Adar Poonawalla, CEO of Serum Institute of India, says the govt restrictions ‘will be eased out very soon once the most vulnerable population starts getting vaccinated’.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Oxford vaccine to cost Rs 219-292 to govt, double for private buyers, says Adar Poonawalla

The Serum Institute of India CEO said Covishield will be sold to the govt and Global Alliance for Vaccines and Immunization countries first and on the private market later.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

Everything we know about Covishield, one of 2 Covid vaccines likely to get nod for use in India

Covishield is Serum Institute of India’s version of the Oxford-AstraZeneca vaccine that had been in the works for several months.

Health Minister Vardhan launches India’s first indigenous pneumococcal vaccine Pneumosil

Pneumosil, developed by SII in collaboration with partners like Bill and Melinda Gates Foundation, will be available at an affordable price, the health ministry said.

Serum Institute has produced 40-50 million doses of Covishield vaccine, says Adar Poonawalla

The Serum Institute CEO also said the vaccine rollout is expected to be slow in the initial phase due to some logistics issues and is expected to pick up once things get sorted.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

On Camera

Bodoland poll loss a wake-up call for Assam BJP. Zubeen’s death puts CM Sarma in a tight spot

Assam CM can’t celebrate that the Congress drew a blank in the Bodoland Territorial Council polls in 2010 as well as 2015, and bagged only one in 2020.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

Aerial warfare analyst Tom Cooper faults India’s military PR, says Pakistan does it better

In post on social media, Cooper narrated experience of MiG-21 researcher from Germany who wanted to attend aircraft’s farewell ceremony in India, and the roadblocks he faced. 

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.